Next generation product: a significant technological advancement that supports tissue regeneration.
The information provided herein is intended for healthcare professionals ONLY and may contain graphic content.
For questions about the products or surgical procedures or the appropriateness for their own conditions, patients should contact their own physicians.
Strattice™ is a sterile reconstructive tissue matrix that supports tissue regeneration.
It is derived from porcine dermis and undergoes non-damaging proprietary processing that removes cells and significantly reduces the key component believed to play a major role in the xenogeneic rejection response.
In a primate model, Strattice demonstrated rapid revascularization, cell repopulation and white cell migration as early as 2 weeks post implantation and mature vascular structure at 6 months post implantation.
Strattice is recommended for use in soft tissue reinforcement, including hernia repair and breast reconstruction.